RACGP - Four things about mRNA vaccines researchers still want to find out
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis | Nature Medicine
Vaccines | Free Full-Text | mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
CDC on X: "CDC recommends Novavax's non-mRNA booster for people ages 18+, for certain situations. This includes those unable or unwilling to receive mRNA #COVID19 vaccines. The Novavax COVID-19 booster targets the
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines
How to choose a COVID-19 vaccine booster shot
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults - The Lancet Infectious Diseases
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
J&J COVID-19 shot gets better boost from Moderna or Pfizer in NIH study | Reuters
Three mRNA COVID-19 vaccine doses very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variants
More adverse reactions following bivalent COVID-19 mRNA booster vaccine
Study backs efficacy of half-dosage mRNA booster| สำนักข่าวกรมประชาสัมพันธ์
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
COVID-19 mRNA booster provides additional protection, most beneficial for older adults
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial - The Lancet Infectious Diseases
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
Plug and Play” mRNA technology works fast, updating vaccines in months : Oregon Health News Blog
Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios | Reuters
